Pasithea Therapeutics Corp.

NASDAQ: KTTA
Share price (5/21/25): $0.93
Market cap (5/21/25): $6.931 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Prospectus supplement with pricing info

Initial registration of new securities

Draft registration statement

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Armistice Capital, LLC

CVI Investments, Inc.

Intracoastal Capital, LLC

News Filter

Announces Pricing of $5 Million Public Offering

Change in Certifying Accountant, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

-- Single Patient in 2mg Cohort With Stage 3 Colon Cancer Who Received 4 Prior Lines of Therapy Achieves Prolonged Stable Disease and Remains on Drug Into 6th Dosing Cycle

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission